UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported):
October
30, 2013
______________
QUINTILES TRANSNATIONAL HOLDINGS INC.
(Exact
name of registrant as specified in its charter)
______________
|
North Carolina |
001-35907 |
27-1341991 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
4820 Emperor Blvd. Durham, North Carolina |
27703 |
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s
telephone number, including area code: (919) 998-2000
Not Applicable
(Former
name or former address, if changed since last report.)
______________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On October 30, 2013, John Ratliff, President and Chief Operating Officer, and a member of the Board of Directors (the “Board”) of Quintiles Transnational Holdings Inc. (the “Company”), informed the Company of his resignation as an officer, employee and member of the Board. While his resignation as a member of the Board is effective immediately, he will remain as an officer and employee until December 31, 2013. Mr. Ratliff’s resignation was a personal decision and was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board accepted Mr. Ratliff’s resignation and noted appreciation for his contributions and service to the Company.
The Company issued a press release announcing the resignation of Mr. Ratliff which is attached hereto as Exhibit 99.1.
|
Item 9.01 |
Financial Statements and Exhibits. |
(d) Exhibits.
See the Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: |
October 31, 2013 |
QUINTILES TRANSNATIONAL HOLDINGS INC. |
||
|
|
|
By: |
/s/ Kevin K. Gordon |
|
|
Kevin K. Gordon |
||||
|
Executive Vice President and Chief Financial Officer |
||||
EXHIBIT INDEX
|
Exhibit |
Description of Document |
|
| 99.1 | Press release dated October 31, 2013 |
Exhibit 99.1
Quintiles President & COO John Ratliff to Leave Company at End of 2013
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--October 31, 2013--Quintiles today announced that John Ratliff has resigned his position as president and chief operating officer (COO) effective December 31, 2013. He has also resigned his role as a member of the Quintiles Transnational Holdings Inc. board of directors.
“On behalf of our board of directors, senior Quintiles management team and our employees around the world, I would like to thank John Ratliff for his leadership and tireless dedication to Quintiles over the past nine years,” said CEO Tom Pike. “Quintiles is known for its strong management team, and I’m confident that these executives will ensure a smooth transition for our customers, employees and the patients we ultimately serve. John helped to grow this team as Quintiles has grown. We wish him well in his future endeavors.”
Ratliff joined Quintiles as chief financial officer in 2004, shortly after the company began its transition from public to private ownership in 2003. In 2006, he was named chief operating officer and was appointed to Quintiles’ board.
“Quintiles is a special company where I have had a tremendous experience, both professionally and personally for almost a decade,” Ratliff said. “The difference this company has made in people’s lives is truly amazing, and I am extremely proud to have played a part in it. I love Quintiles and wish the best of luck to the entire organization,” Ratliff concluded.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
CONTACT:
Quintiles
Phil Bridges, + 1-919-998-1653
Media
Relations
phil.bridges@quintiles.com
Mobile: +1-919-457-6347
or
Karl
Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com